Cargando…
miR-522-3p Promotes Tumorigenesis in Human Colorectal Cancer via Targeting Bloom Syndrome Protein
miR-522-3p is known to degrade bloom syndrome protein (BLM) and enhance expression of other proto-oncogenes, leading to tumorigenesis. This study aimed to investigate the molecular mechanisms of miR-522-3p in human colorectal cancer (CRC) cells. Expressions of miR-522-3p in CRC and adjacent tissues,...
Autores principales: | Shuai, Feng, Wang, Bo, Dong, Shuxiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cognizant Communication Corporation
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844714/ https://www.ncbi.nlm.nih.gov/pubmed/29386092 http://dx.doi.org/10.3727/096504018X15166199939341 |
Ejemplares similares
-
Retraction notice to “miR-522-3p Promotes Tumorigenesis in Human Colorectal Cancer via Targeting Bloom Syndrome Protein” [Oncology Research 26(7) (2018) 1113–1121]
por: Shuai, Feng, et al.
Publicado: (2022) -
Targeting of ΔNp63α by miR‐522 promotes the migration of breast epithelial cells
por: Dong, Yuanyuan, et al.
Publicado: (2021) -
MiR-522-3p Targets Transcription Factor 4 to Overcome Cisplatin Resistance of Gastric Cells
por: Ma, Guofeng, et al.
Publicado: (2022) -
miR-522-3p Promotes Osteosarcoma Cell Growth By Regulating Glucose Uptake And GLUT1 Expression
por: Chen, Rong, et al.
Publicado: (2019) -
CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer
por: Zhang, Haiyang, et al.
Publicado: (2020)